This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Anthem's (ANTM) Q4 Earnings Miss Estimates, Rise Y/Y
by Zacks Equity Research
Anthem's (ANTM) fourth-quarter results reflect solid revenues, partially offset by increased expenses.
HCA Healthcare (HCA) Q4 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) Q4 results gain traction from better revenues and increased admissions.
Anthem (ANTM) Gears Up for Q4 Earnings: What's in Store?
by Zacks Equity Research
Anthem's (ANTM) fourth-quarter results are likely to reflect a strong revenue stream.
What's in Store for HCA Healthcare's (HCA) Q4 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) Q4 results are likely to reflect healthy growth in revenues and admissions.
Is Molina Healthcare (MOH) a Worthy Stock to Pick Right Now?
by Zacks Equity Research
Is Molina Healthcare (MOH) a great pick from the value investor's perspective right now? Read on to know more.
Can Molina (MOH) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Molina (MOH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Molina Healthcare to Boost Medicaid Via Strategic Buyout
by Zacks Equity Research
Molina Healthcare (MOH) aims to scale up its Medicaid business by acquiring NextLevel Health.
Will UnitedHealth Exhibit Strong Share Price Gains in 2020?
by Zacks Equity Research
UnitedHealth (UNH) will continue to show operating efficiency in 2020 but its shares might be subject to volatility due to regulatory ambiguity through 2020 elections.
Why Should You Retain Molina Healthcare in Your Portfolio?
by Zacks Equity Research
On the back of its restructuring initiatives and solid membership, Molina Healthcare (MOH) holds enough potential to reap benefits for investors.
HMO Industry Outlook: Multiple Levers to Drive Growth
by Sapna Bagaria
Aging U.S population, consolidation, use of technology and growing health service businesses provide ample scope for the industry to grow.
Molina Healthcare Wins Kentucky Medicaid Managed Care Deal
by Zacks Equity Research
Molina Healthcare's (MOH) Kentucky Medicaid Managed Care contract win to aid 2020 premium revenues.
Molina (MOH) Up 11.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Molina Healthcare (MOH) Q3 Earnings Surpass, Increase Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) third-quarter earnings benefit from lower expenses.
Molina (MOH) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of 3.32% and 2.92%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Healthcare Stock Earnings Slated on Oct 29: HCA, MOH & More
by Zacks Equity Research
Increasing demands for products and services are likely to have driven earnings for players in the healthcare industry.
What's in Store for Molina Healthcare (MOH) Q3 Earnings?
by Zacks Equity Research
Molina Healthcare's (MOH) third-quarter results are likely to be affected by soft revenues, partly offset by improved marketplace business.
HCA Healthcare (HCA) to Post Q3 Earnings: What to Expect
by Zacks Equity Research
HCA Healthcare's (HCA) third-quarter results are likely to reflect elevated expenses, partly offset by higher topline from increase in admissions and licensed beds.
Anthem's (ANTM) Q3 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) third-quarter earnings gain from increased revenues.
Centene's (CNC) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Centene's (CNC) third-quarter earnings gain traction from higher revenues.
What to Expect for Universal Health's (UHS) Q3 Earnings
by Zacks Equity Research
Universal Health (UHS) is likely to have benefited from strong segmental performances at Acute Care and Behavioral Health in Q3, partly offset by high costs.
Anthem (ANTM) Gears Up for Q3 Earnings: What's in Store?
by Zacks Equity Research
Anthem (ANTM) is likely to have gained from solid revenues in the third quarter.
Nokia (NOK) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Solid progress in its expansion areas of Software and Enterprise and excellent momentum in IP Routing business are likely to have benefited Nokia's (NOK) third-quarter 2019 financial results.
Molina Healthcare Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Molina Healthcare has been struggling lately, but the selling pressure may be coming to an end soon.
What's in the Cards for Centene's (CNC) Earnings in Q3?
by Zacks Equity Research
Centene's (CNC) third-quarter earnings are likely to have grown on the back of solid revenues.
UnitedHealth Group (UNH) in Focus: Stock Moves 8.2% Higher
by Zacks Equity Research
UnitedHealth Group (UNH) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.